Cranberry
Vaccinii macrocarpi fructus
Vaccinium macrocarpon Aiton
HOS-216042hmpc:vaccinii-macrocarpi-fructus
Botanische Abbildung · Noch nicht verfügbar
Für die botanische Originalangabe wurde noch kein eindeutig zugeordnetes Bild gefunden.
- Themengebiete laut EMA
- Urinary tract and genital disorders
- Ergebnis der Bewertung laut EMA
- European Union herbal monograph
- Kombination laut EMA
- Nein
Pflanzen–Arzneimittel-Beziehungen 1 belegte Zuordnungen
Explizite Einschränkungen aus der Monographie, verknüpft mit eindeutig bezeichneten Wirkstoffen. Die Aussage gilt im Zubereitungs- und Anwendungskontext der Quelle. Ein klinischer Schweregrad wird daraus nicht abgeleitet.
tacrolimus
Laut Quelle vermeidenTraditionelle Anwendung · Quellenspalte · Schweregrad: nicht angegeben
HOS-216042HOS-085202RxNorm 42316
Decreased tacrolimus serum levels have been reported from the concomitant use of cranberry juice and tacrolimus in a renal allografted patient. The concomitant use of cranberry preparations and tacrolimus should be avoided (see section 4.3. ‘Contraindications’).
Zubereitungskontext & Beleg
Wortlaut der zugeordneten Einschränkung:
The concomitant use of cranberry preparations and tacrolimus should be avoided (see section 4.3. ‘Contraindications’).
1. Name of the medicinal product To be specified for the individual finished product. 2. Qualitative and quantitative composition 1, 2 Well-established use Traditional use With regard to the registration application of Article 16d(1) of Directive 2001/83/EC Vaccinium macrocarpon Aiton, fructus (cranberry fruit) i) Herbal substance Not applicable. ii) Herbal preparations Expressed juice from the fresh fruit (DER 1: 0.6- 0.9) 3. Pharmaceutical form Well-established use Traditional use Herbal preparations in liquid dosage forms for oral use. The pharmaceutical form should be described by the European Pharmacopoeia full standard term. 4. Clinical particulars 4.1. Therapeutic indications Well-established use Traditional use Indication 1) Traditional herbal medicinal product used for relief of symptoms of mild recurrent lower urinary tract infections such as burning sensation during urination and/or frequent 1 The declaration of the active substance(s) for an individual finished product should be in accordance with relevant herbal quality guidance. 2 Detailed specifications for the herbal substance shall be given by references to bibliographic sources in absence of a monograph in the European Pharmacopoeia, a national pharmacopoeia or national codex currently used officially in a Member State. European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus EMA/HMPC/49135/2017 Page 3/7 Well-established use Traditional use urination in women, after serious conditions have been excluded by a medical doctor. Indication 2) Traditional herbal medicinal product used for prevention of recurrent uncomplicated lower urinary tract infections in women, after serious conditions have been excluded by a medical doctor. The product is a traditional herbal medicinal product for use in the specified indication exclusively based upon long-standing use. 4.2. Posology and method of administration Well-established use Traditional use Posology Female adults and elderly Indication 1) 50-60 ml expressed juice 2 - 4 times daily Indication 2) 30 ml expressed juice once daily The use in children and adolescents under 18 years of age is not recommended (see section 4.4 ‘Special warnings and precautions for use’). The use in men is not recommended (see section 4.4 ‘Special warnings and precautions for use’). Duration of use Indication 1) If the symptoms persist for more than 4 days during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Indication 2) No restriction. If the patient experience symptoms of urinary tract infection during the use of the medicinal product, a doctor or a qualified health care European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus EMA/HMPC/49135/2017 Page 4/7 Well-established use Traditional use practitioner should be consulted. Method of administration Oral use. 4.5. Interactions with other medicinal products and other forms of interaction Well-established use Traditional use Cranberry juice and other cranberry products may potentiate the effect of warfarin and therefore concomitant use should be avoided (see section 4.3. ‘Contraindications’). Decreased tacrolimus serum levels have been reported from the concomitant use of cranberry juice and tacrolimus in a renal allografted patient. The concomitant use of cranberry preparations and tacrolimus should be avoided (see section 4.3. ‘Contraindications’).PDF SHA-256:
5f61fe8336ebd5237bcaa995f837a6ea30d8b416102d2a1d0e342433fee84e01Die Zuordnung verbindet dieses HMPC-Quellenprofil mit dem genannten Wirkstoff. Sie ist keine Aussage über jedes Präparat aus dieser Pflanzenart.
Keine oder wenige Zuordnungen bedeuten nicht, dass keine Wechselwirkungen bestehen. Nicht eindeutig zuordenbare und verneinte Aussagen bleiben im Originalabschnitt nachlesbar.
Sicherheit aus der Monographie Originalabschnitte
Englische Originalabschnitte mit unveränderten Spalten für etablierte und traditionelle Anwendung. Aussagen gelten für die im Dokument genannten Zubereitungen und Anwendungsarten. Aus ihnen werden hier keine Interaktionspaare oder Schweregrade abgeleitet.
Final European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus ↗
PDF abgerufen: 25.10.2026 · 7 Seiten · automatisch ausgelesen
Zubereitungs- und Anwendungskontext · Originaltext
Originalkontext vor Abschnitt 4.3, einschließlich der Angaben zu Zubereitungen und Anwendung. Buchstaben und Nummern der Zubereitungen werden in den Sicherheitsabschnitten wieder aufgegriffen.
1. Name of the medicinal product
To be specified for the individual finished product.
2. Qualitative and quantitative composition 1, 2
Well-established use Traditional use
With regard to the registration application of
Article 16d(1) of Directive 2001/83/EC
Vaccinium macrocarpon Aiton, fructus
(cranberry fruit)
i) Herbal substance
Not applicable.
ii) Herbal preparations
Expressed juice from the fresh fruit (DER 1: 0.6-
0.9)
3. Pharmaceutical form
Well-established use Traditional use
Herbal preparations in liquid dosage forms for
oral use.
The pharmaceutical form should be described by
the European Pharmacopoeia full standard term.
4. Clinical particulars
4.1. Therapeutic indications
Well-established use Traditional use
Indication 1)
Traditional herbal medicinal product used for
relief of symptoms of mild recurrent lower
urinary tract infections such as burning
sensation during urination and/or frequent
1 The declaration of the active substance(s) for an individual finished product should be in accordance with relevant herbal
quality guidance.
2 Detailed specifications for the herbal substance shall be given by references to bibliographic sources in absence of a
monograph in the European Pharmacopoeia, a national pharmacopoeia or national codex currently used officially in a
Member State.
European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus
EMA/HMPC/49135/2017 Page 3/7
Well-established use Traditional use
urination in women, after serious conditions
have been excluded by a medical doctor.
Indication 2)
Traditional herbal medicinal product used for
prevention of recurrent uncomplicated lower
urinary tract infections in women, after serious
conditions have been excluded by a medical
doctor.
The product is a traditional herbal medicinal
product for use in the specified indication
exclusively based upon long-standing use.
4.2. Posology and method of administration
Well-established use Traditional use
Posology
Female adults and elderly
Indication 1)
50-60 ml expressed juice 2 - 4 times daily
Indication 2)
30 ml expressed juice once daily
The use in children and adolescents under 18
years of age is not recommended (see section
4.4 ‘Special warnings and precautions for use’).
The use in men is not recommended (see
section 4.4 ‘Special warnings and precautions
for use’).
Duration of use
Indication 1)
If the symptoms persist for more than 4 days
during the use of the medicinal product, a doctor
or a qualified health care practitioner should be
consulted.
Indication 2)
No restriction.
If the patient experience symptoms of urinary
tract infection during the use of the medicinal
product, a doctor or a qualified health care
European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus
EMA/HMPC/49135/2017 Page 4/7
Well-established use Traditional use
practitioner should be consulted.
Method of administration
Oral use.Kontext im Original-PDF öffnen ↗4.3 · Gegenanzeigen
Contraindications
4.3. Contraindications
Well-established use Traditional use
Hypersensitivity to cranberry (Vaccinium
macrocarpon Ait.) fruit.
Patients with kidney disorders who experienced
recurrent urinary tract infections require medical
supervision.
Concomitant use with tacrolimus and warfarin
(see section 4.5 ‘Interactions with other
medicinal products and other forms of
interaction’).Original-PDF · Seite 5 ↗4.4 · Warnhinweise und Vorsichtsmaßnahmen
Special warnings and precautions for use
4.4. Special warnings and precautions for use
Well-established use Traditional use
The use in children and adolescents under 18
years of age is not recommended because data
is not sufficient and medical advice should be
sought.
The use in men and pregnant women is not
recommended because lower urinary tract
symptoms in these populations require medical
supervision.
Cranberry concentrate has a high content of
oxalate, and there may be an increased risk of
stone formation in the urinary tract in patients
with stone history.
If the symptoms worsen or if complaints such as
fever, dysuria, spasms, or blood in urine occur
during the use of the medicinal product, a
doctor or a qualified health care practitioner
should be consulted.
European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus
EMA/HMPC/49135/2017 Page 5/7Original-PDF · Seite 5 ↗4.5 · Wechselwirkungen
Interactions with other medicinal products and other forms of interaction
4.5. Interactions with other medicinal products and other forms of
interaction
Well-established use Traditional use
Cranberry juice and other cranberry products
may potentiate the effect of warfarin and
therefore concomitant use should be avoided
(see section 4.3. ‘Contraindications’).
Decreased tacrolimus serum levels have been
reported from the concomitant use of cranberry
juice and tacrolimus in a renal allografted
patient. The concomitant use of cranberry
preparations and tacrolimus should be avoided
(see section 4.3. ‘Contraindications’).Original-PDF · Seite 6 ↗4.8 · Nebenwirkungen
Undesirable effects
4.8. Undesirable effects
Well-established use Traditional use
Gastrointestinal disorders: nausea, diarrhoea
and dyspepsia. The frequency is not known.
Skin and subcutaneous tissue disorders:
urticaria and rash. The frequency is not known.
If other adverse reactions not mentioned above
occur, a doctor or a qualified health care
practitioner should be consulted.
European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus
EMA/HMPC/49135/2017 Page 6/7Original-PDF · Seite 6 ↗Dokumentfassung nachweisen
SHA-256: 5f61fe8336ebd5237bcaa995f837a6ea30d8b416102d2a1d0e342433fee84e01
Der Hash kennzeichnet die abgerufene Datei. Die Dokumentfassung und der Bearbeitungsstatus des Pflanzenprofils sind getrennte Angaben.
Importstand: 25.10.2026 · Aktuelles EMA-Quellenprofil ↗
Dokumente beim Herausgeber · 9
Originaltitel bleiben erhalten. Entwürfe, ältere Fassungen und ergänzende Berichte können nebeneinander vorliegen; der Profilstatus bestimmt nicht die Gültigkeit jedes Dokuments.
- Call for scientific data for use in HMPC assessment work on Vaccinium macrocarpon Aiton, fructus
- Overview of comments received on European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus (EMA/HMPC/49135/2017)
- Draft European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus - First version
- Final European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus
- Opinion of the HMPC on a European Union herbal monograph on Vaccinium macrocarpon Aiton, fructus
- Draft List of references supporting the assessment of Vaccinium macrocarpon Aiton, fructus - First version
- Final list of references supporting the assessment of Vaccinium macrocarpon Aiton, fructus
- Draft assessment report on Vaccinium macrocarpon Aiton, fructus - First version
- Final assessment report on Vaccinium macrocarpon Aiton, fructus
Dokumentenlinks geprüft: 25.10.2026
Quellenstand & Originalangaben
- Originalstatus
- F: Assessment finalised
- Zuletzt geändert laut EMA
- 21/02/2023
- Erstveröffentlichung laut EMA
- 14/10/2015
- Erfolgreicher Quellenabruf
- 25.10.2026